Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667072 | SCV000791465 | likely pathogenic | Deficiency of steroid 11-beta-monooxygenase | 2017-10-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001040067 | SCV001203622 | pathogenic | not provided | 2022-11-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551903). This premature translational stop signal has been observed in individual(s) with adrenal hyperplasia (PMID: 9435454). This variant is present in population databases (no rsID available, gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln19*) in the CYP11B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP11B1 are known to be pathogenic (PMID: 8506298, 26476331). |
Baylor Genetics | RCV000667072 | SCV004215342 | pathogenic | Deficiency of steroid 11-beta-monooxygenase | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005049638 | SCV005675156 | likely pathogenic | Deficiency of steroid 11-beta-monooxygenase; Glucocorticoid-remediable aldosteronism | 2024-01-04 | criteria provided, single submitter | clinical testing |